CAMBRIDGE, Mass., April 12, 2021 /PRNewswire/ -- Akebia
Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company
with the purpose to better the lives of people impacted by kidney
disease, today announced that John P.
Butler, Chief Executive Officer of Akebia, will present at
the 20th Annual Needham Virtual Healthcare Conference on
Thursday, April 15 at 1:30 p.m. ET.
A live webcast of the presentation can be accessed through the
Investors section of the Company's website at
https://ir.akebia.com. A replay of the webcast will be available
for approximately 30 days following the conference.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is
a fully integrated biopharmaceutical company with the purpose to
better the lives of people impacted by kidney disease. The Company
was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more
information, please visit our website at www.akebia.com, which does
not form a part of this release.
Akebia Therapeutics Contact
Kristen K. Sheppard, Esq.
ir@akebia.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-20th-annual-needham-virtual-healthcare-conference-301266301.html
SOURCE Akebia Therapeutics, Inc.